
Quality is the documentation.
Defensible certainty is not a tagline — it is a paper trail. Every claim we make about a compound is one you can verify against the analytical record for the lot in hand.
Held to a documented standard
At CliniPeptide, quality is the documentation: every compound supplied for laboratory research is produced under controlled conditions and released only against a verifiable analytical record. Identity and purity are independently corroborated, never self-attested, so the evidence travels with the lot in hand.
Manufacturing Standards
CliniPeptide research compounds are produced in cGMP-compliant, FDA-audited facilities under controlled, repeatable process conditions, so material destined for laboratory research is synthesized and purified to a defined, documented specification rather than to an undocumented best effort.
Analytical Verification
Each lot is characterized against a defined release specification: purity is measured at ≥99% by HPLC and molecular identity is confirmed by ESI-MS, so the material you investigate in vitro is verified to be the compound you ordered, at the purity stated on the record.
Independent Testing
Identity, purity, endotoxins, sterility, and heavy metals are evaluated through rigorous third-party testing at an independent ISO/IEC 17025-accredited laboratory, so the analytical findings supporting each research compound are corroborated against an external bench, not asserted by us.
Documentation
Every production batch is released against a lot-specific Certificate of Analysis that records the analytical results and methods for that exact lot, giving research teams a defensible paper trail they can verify and cite for the material in hand.
Research-Use-Only Standard
CliniPeptide products are research materials supplied to qualified researchers and institutions for laboratory research only; they have been studied solely in laboratory and preclinical research contexts and are not drugs, supplements, or medical devices, and are not for any human or veterinary use.
How every lot is verified
Material moves from synthesis to release only after it clears each gate in a five-step workflow — and the record travels with it.
Synthesis
Each peptide is synthesized and purified under controlled, cGMP-compliant process conditions in an FDA-audited facility before any material is advanced for analysis.
Independent Testing
A sample from the lot undergoes rigorous third-party testing at an independent ISO/IEC 17025-accredited laboratory for identity, purity, endotoxins, sterility, and heavy metals.
Quality Review
Analytical results are reviewed against the release specification, confirming purity ≥99% by HPLC and identity by ESI-MS before the lot can proceed.
Documentation
The verified results and methods are compiled into a lot-specific Certificate of Analysis tied to that exact production batch.
Release
Only after the record is complete and the specification is met is the lot released for laboratory research use, with its Certificate of Analysis traveling alongside it.
What the documentation actually means
A percentage, not a promise
Reversed-phase high-performance liquid chromatography separates a sample into its components and quantifies the target peptide as a percentage of the whole. A ≥99% result means the chromatogram is dominated by one clean peak — the compound you ordered.
Identity, confirmed by mass
Electrospray-ionization mass spectrometry (ESI-MS) measures the molecular mass of the compound and matches it against the expected value for its sequence. Purity tells you how much; mass confirmation tells you what.
Why it belongs on the record
Many peptides are supplied as salts (e.g., acetate or trifluoroacetate). Counterion content affects net peptide mass — so it belongs on the same page as purity and identity, not buried or omitted.
Corroborated, not self-attested
Characterization is supported by third-party analysis, so purity and identity are not claims we make about ourselves — they are corroborated against an external analytical bench.

Research Use Only — clearly, not in the fine print
CliniPeptide products are research materials. They are not drugs, supplements, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease, or for any human or veterinary use or consumption. Materials are supplied to qualified researchers, physicians, and institutions for laboratory research only. Manufactured for CliniPeptide (VSABF, LLC) by FDA-registered contract manufacturer.
